Lung cancer discovered in the preclinical phase of development
Drukin, E.Ia.
Voprosy Onkologii 21(4): 51-55
1975
ISSN/ISBN: 0507-3758 PMID: 1198986 Document Number: 94453
Document emailed within 1 workday
Related Documents
Yamashita, T.; Takashina, M.; Ito, S.; Fujita, T.; Ishikawa, Y. 1971: Case of multiple cancer of 5 different locations discovered independently in the period of 10 years--scapular sarcoma and cancer of the sigmoid, right kidney, appendix and lung Gan no Rinsho. Japan Journal of Cancer Clinics 17(10): 769-773Korstanje, C. 2003: Integrated assessment of preclinical data: shifting high attrition rates to earlier phase drug development Current Opinion in Investigational Drugs 4(5): 519-521
Smith, A.C.; Barrett, D.; Stedham, M.A.; el-Hawari, M.; Kastello, M.D.; Grieshaber, C.K.; Boyd, M.R. 1987: Preclinical toxicology studies of 4-ipomeanol: a novel candidate for clinical evaluation in lung cancer Cancer Treatment Reports 71(12): 1157-1164
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
Dempke, W. 2007: Preclinical and clinical effects of erythropoietin in the management of anaemia in patients with non-small cell lung cancer Anticancer Research 27(4a): 1745-1757
Neill, H.B.; Miller, A.A.; Clamon, G.H.; Perry, M.C.; Crawford, J.; Green, M.R. 1997: A phase Ii study evaluating the efficacy of carboplatin, etoposide, and paclitaxel with granulocyte colony-stimulating factor in patients with stage IIIB and IV non-small cell lung cancer and extensive small cell lung cancer Seminars in Oncology 24(4 Suppl 12: S12
Matsui, Y.; Ohshima, S.; Kado, M.; Nakayama, M.; Shimokata, K.; Sakai, S.; Ito, F.; Chikata, E.; Hara, K.; Kanda, T. 1985: A phase Ii study of oral VP-16 in primary lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 12(9): 1801-1807
Storniolo, A.M.; Allerheiligen, S.R.; Pearce, H.L. 1997: Preclinical, pharmacologic, and phase i studies of gemcitabine Seminars in Oncology 24(2 Suppl 7: S7
Eagan, R.T.; Creagan, E.T.; Ingle, J.N.; Frytak, S.; Rubin, J. 1978: Phase II evaluation of maytansine in patients with metastatic lung cancer Cancer Treatment Reports 62(10): 1577-1579
Yokoyama, A.; Nakai, Y.; Yoneda, S.; Kurita, Y.; Niitani, H.; Taguchi, T. 1996: A late phase Ii study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase Ii Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1681-1688
Adsumelli, R.S.N.; Elimian, A.; Wiencek, V.; Benveniste, H.D.; Glass, P.S.A.; Quirk, J.Gerald. 2006: Change in pulse pressure during the preclinical phase of preeclampsia Journal of Reproductive Medicine 51(1): 26-30
Valls-Pedret, C.; Molinuevo, J.é L.; Rami, L. 2010: Early diagnosis of Alzheimer's disease: the prodromal and preclinical phase Revista de Neurologia 51(8): 471-480
Smith, D.B.; Thatcher, N.; Steward, W.P.; Brear, G.; Carroll, K.B. 1986: A phase II study of cyclophosphamide as a 24-hr infusion in advanced non-small cell lung cancer European Journal of Cancer and Clinical Oncology 22(4): 435-437
Thongprasert, S. 2000: Phase Ii study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer Journal of the Medical Association of Thailand 83(5): 549-553
Grunberg, S.M.; Itri, L.M. 1987: Phase Ii study of isotretinoin in the treatment of advanced non-small cell lung cancer Cancer Treatment Reports 71(11): 1097-1098
Gatzemeier, U.; Manegold, C.; Eberhard, W.; Wilke, H.J.; Chomy, F.; Chomy, P.; Khayat, D.; Blatter, J.; Seeber, S.; Drings, P. 1998: Ifosfamide and gemcitabine: a phase Ii trial in advanced inoperable non-small cell lung cancer Seminars in Oncology 25(1 Suppl 2: 15-18
Niklinska, W.; Laudanski, J.; Niklinski, J. 2001: G1 phase of the cell cycle control and lung cancer: biological and clinical implications. Minireview Neoplasma 48(3): 157-163
Lampl, L.; Bock, K.H.; Hartel, W.; Helm, M.; Tisch, M.; Seifried, E. 1992: Disorders of hemostasis after polytrauma. on the extent of intrinsic fibrinolytic activity in the preclinical phase Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 63(4): 305-309
Splinter, T.; Kok, T.; Kho, S.; Lameris, H.; ten Kate, F.; Dalesio, O.; Dolman, B.; Palmen, F.; Bouvy, J.; Burghouts, J. 1986: A multicenter phase Ii trial of cisplatin and oral etoposide (VP-16) in inoperable non-small-cell lung cancer Seminars in Oncology 13(3 Suppl 3: 97-103
Natale, R.B. 1996: Preliminary results of a phase I/Ii clinical trial of paclitaxel and carboplatin in non-small cell lung cancer Seminars in Oncology 23(6 Suppl 16: 51-54